Clinical Trial Update: the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether febuxostat affects coronary plaque volume in patients with chronic stable angina and hyperuricemia; the study status is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Angina

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Yokohama City University Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED